Lilly's orforglipron posts Phase 3 diabetes results; six new trials registeredSep 18Weekly roundup, 7 itemsEli Lillyorforglipron
FDA approves supplement 7 for Eli Lilly's Retevmo (selpercatinib)Jul 14Regulatory decisionEli Lillyselpercatinib
FDA approves efficacy supplement for Eli Lilly's Retevmo (selpercatinib)Jul 14Regulatory decisionEli LillyenGene, Inc.
Sign inSign in